Loading...

Patent Expiry And Payer Pressures Will Check Future Performance

Published
30 Aug 25
AnalystLowTarget's Fair Value
US$56.92
30.7% overvalued intrinsic discount
04 Sep
US$74.38
Loading
1Y
90.9%
7D
0.09%

Author's Valuation

US$56.9

30.7% overvalued intrinsic discount

AnalystLowTarget Fair Value